ENTITY

SIGA Technologies (SIGA US)

18
Analysis
Health CareUnited States
SIGA Technologies, Inc. operates as a commercial-stage pharmaceutical company. The Company offers oral formulation of an antiviral drug for the treatment of human smallpox disease caused by variola virus.
more
Refresh
14 May 2024 07:10Issuer-paid

SIGA Technologies - Optimizing the TPOXX value proposition

SIGA’s Q124 results were marked by material BARDA and international TPOXX deliveries and highlighted the company’s strategic push towards...

Share
05 Apr 2024 07:10Issuer-paid

SIGA Technologies - Positive signals abound

SIGA Technologies announced a strategic step in fortifying its distribution partner, Meridian, allowing greater control over planning and executing...

Share
18 Mar 2024 19:10Issuer-paid

SIGA Technologies - Onwards and upwards with strong FY23

SIGA Technologies has delivered its best top-line performance in the last five years, supported by a late surge in TPOXX deliveries across both...

Share
24 Jan 2024 01:10Issuer-paid

SIGA Technologies - New captain to steer the ship

SIGA Technologies has appointed Dr Diem Nguyen as its new chief executive officer (CEO), effective 27 January 2024. She will be spearheading the...

Share
11 Nov 2023 13:10Issuer-paid

SIGA Technologies - International momentum building towards year-end

SIGA recapped several key developments in its Q3 update, signalling strong top-line momentum going into Q423. Most notably, the recent $18m...

Share
x